AbCellera Biologics Inc. (ABCL) Institutional Ownership

Ownership Summary

A total of 2 institutions have reported a stake in AbCellera Biologics Inc. (NASDAQ:ABCL) as of December 2025, according to recent 13F filings with the SEC.

• These investors collectively held 0.0% of the company's total shares outstanding in December 2025, down from 34.7% in September 2025.
• Quarterly data indicates a 16.49% shift in institutional share volume, and the annual owner count reflects a decrease of 98.59%.
• A review of institutional activity for AbCellera Biologics shows 1 of 2 filers increasing their positions, while 0 reduced their stake, and 1 remained unchanged.
• The total number of shares held by institutions in AbCellera Biologics increased to 34.02K as of December 2025, a net change of up by 4.82K shares quarter on quarter, and down 113.67Mn shares year over year.
• Green Alpha Advisors, LLC continues to be the largest institutional holder of AbCellera Biologics as of December 31, 2025, with a position of 27.59K shares, representing 0.01% of the company's outstanding stock.
• Among the most significant buyers of AbCellera Biologics during December 2025 were Green Alpha Advisors, LLC (4.82K).
• The top 2 institutional holders of AbCellera Biologics for the quarter ending December 2025 included Green Alpha Advisors, LLC (27.59K), Pacifica Partners Inc. (6.43K).